Nucleic Acid Building Blocks
3’-deoxyadenosine Abogen Cansino biologics Conference Cordycepin Coronavirus Vaccine COVID-19 dNTPs Exhibition GMP site Immorna investment LNP mRNA NTPs Nucleosides Nucleotides Oligo Oligonucleotides Phosphoramidite Phosphoramidites RNA sequences Solid-phase synthesis synthesis of oligonucleotides Vaccine
- PatisiranCAS NO.: 1420706-45-1Synonyms: ALN-18328Molecular Formula: C412H520N148O290P40Molecular Weight: N/A Application: Patisiran is a medication used for the treatment of polyneuropathy in people with hereditary transthyretin-mediated amyloidosis. It is a …
- GivosiranCAS NO.: 1639325-43-1Synonyms: ALN-AS1Molecular Formula: C78H139N11O30Molecular Weight: 1709.968872 Da Application: Givosiran is indicated for the treatment of adults with acute hepatic porphyria, a genetic disorder resulting in the …
- Lumasiran sodiumCAS NO.: 1834612-06-4Synonyms: N/AMolecular Formula: N/AMolecular Weight: N/A Application: Lumasiran sodium is an investigational RNA interference (RNAi) therapeutic agent, reduces hepatic oxalate production by targeting glycolate oxidase. Lumasiran …
- Inclisiran sodiumCAS NO.: 1639324-58-5Synonyms: ALN-PCSsc: InclisiranMolecular Formula: C529H664F12N176O316P43S6Molecular Weight: N/A Application: Inclisiran sodium is a double-stranded small interfering RNA (siRNA) molecule that inhibits the transcription of PCSK-9. Inclisiran can …
- VutrisiranCAS NO.: 1867157-35-4Synonyms: ALN-TTRsc02Molecular Formula: N/AMolecular Weight：16345 Application: Vutrisiran is a liver-directed, investigational, small interfering ribonucleic acid (siRNA) agent. Vutrisiran can be used for transthyretin (TTR)-mediated amyloidosis research. …